ERK5 inhibitors (Ikena Oncology)

N/A

Report date: 2025/03/18 18:17:41
NME

Base Information

Drug NameERK5 inhibitors (Ikena Oncology)
Drug Alias NameExtracellular signal related kinase-5 inhibitor (Ikena Oncology)Ras-signaling modulators (Ikena Oncology)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExtracellular-signal-regulated kinase 5 inhibitors
TargetsExtracellular-signal-regulated kinase 5
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsAdenocarcinoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIkena Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesIkena Oncology Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsPancreatic NeoplasmsAdenocarcinoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A